Pathway Medical Technologies, Inc. (Pathway), located in Kirkland, Washington was founded to develop, manufacture and market innovative medical devices intended for the treatment of arterial disease.
The company's initial focus is on Peripheral Arterial Disease (PAD), which affects 12 million in the U.S. Because the disease is systemic, those with the disease are at increased risk for heart attacks and stroke. Many people mistake their PAD symptoms for aging, and so go undiagnosed until the disease has progressed to a later stage.
Through our management team, sophisticated investors and key clinical thought leaders, Pathway is committed to bringing unique technology to the marketplace to treat severe PAD. Technologies such as ours, combined with national screening initiatives, are increasing the options for patients suffering from PAD and helping them avoid long-term complications of the disease.
To design, develop, manufacture and distribute innovative medical devices to health care professionals in an ongoing effort to improve the lives of their patients.